Related Experiment Videos
Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia
Robert S Decker1, Marlene L Decker, Irina Kulikovskaya
1Feinberg Cardiovascular Research Institute, Tarry 12-733, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave, Chicago, IL 60611-3008, USA. r-decker@northwestern.edu
Circulation
|February 9, 2005
Summary
Myosin-binding protein C (MyBP-C) dephosphorylation during ischemia and reperfusion contributes to contractile dysfunction in canine hearts. This dephosphorylation alters myofibril structure, reducing cross-bridge formation and prolonging myocardial stunning.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
Background:
- Chronic low-flow ischemia induces persistent contractile dysfunction in canine myocardium post-reperfusion.
- Investigating the role of myosin-binding protein C (MyBP-C) phosphorylation in this dysfunction is crucial.
Purpose of the Study:
- To determine if alterations in the phosphorylation state of MyBP-C contribute to myocardial contractile dysfunction following ischemia-reperfusion.
Main Methods:
- Analysis of MyBP-C phosphorylation status in canine myocardium subjected to low-flow ischemia and reperfusion.
- Assessment of actomyosin cross-bridge formation and myofibril structure.
Main Results:
- MyBP-C becomes dephosphorylated during low-flow ischemia.
- Actomyosin cross-bridge formation decreases due to thick filament disassembly during ischemia.
- MyBP-C remains dephosphorylated and undergoes accelerated degradation during reperfusion.
Conclusions:
- MyBP-C dephosphorylation may trigger structural changes in myofibrils, impairing myosin head-actin interaction.
- Reduced actomyosin cross-bridge formation likely contributes to post-ischemic contractile dysfunction.
- Accelerated MyBP-C breakdown during reperfusion may prolong myocardial stunning.